Tenaya Therapeutics Inc [NASDAQ: TNYA] jumped around 0.04 points on Wednesday, while shares priced at $0.53 at the close of the session, up 7.49%.
Compared to the average trading volume of 3.51M shares, TNYA reached a trading volume of 2767904 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Tenaya Therapeutics Inc [TNYA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNYA shares is $10.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNYA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Tenaya Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 10, 2024. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on November 30, 2023, representing the official price target for Tenaya Therapeutics Inc stock. Previously, the target price had yet another raise to $25, while H.C. Wainwright analysts kept a Buy rating on TNYA stock.
The Average True Range (ATR) for Tenaya Therapeutics Inc is set at 0.04 The Price to Book ratio for the last quarter was 0.72, with the Price to Cash per share for the same quarter was set at 0.54.
How has TNYA stock performed recently?
Tenaya Therapeutics Inc [TNYA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.24. With this latest performance, TNYA shares gained by 5.83% in over the last four-week period, additionally sinking by -85.25% over the last 6 months – not to mention a drop of -87.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNYA stock in for the last two-week period is set at 61.01, with the RSI for the last a single of trading hit 71.22, and the three-weeks RSI is set at 53.22 for Tenaya Therapeutics Inc [TNYA]. The present Moving Average for the last 50 days of trading for this stock 0.4841, while it was recorded at 0.4762 for the last single week of trading, and 1.4875 for the last 200 days.
Tenaya Therapeutics Inc [TNYA]: Deeper insight into the fundamentals
Tenaya Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.68 and a Current Ratio set at 6.68.
Insider trade positions for Tenaya Therapeutics Inc [TNYA]
The top three institutional holders of TNYA stocks are: COLUMN GROUP LLC with ownership of 9.4 million shares, which is approximately 10.968%. RA CAPITAL MANAGEMENT, L.P., holding 7.62 million shares of the stock with an approximate value of $$23.63 million in TNYA stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$20.87 million in TNYA stock with ownership which is approximately 7.8558%.
